Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer

Overview of attention for article published in Investigational New Drugs, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 8 X users

googleplus: 1 Google+ user

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Αλέξανδρος Σφακιανάκης, 30 Oct 2018

Eriko Yokoi http://dlvr.it/Qpwg1z